More articles from psychopharmacology for the clinician

Open Access
Atypical antipsychotics, dystonia, and psychotic depression: old solutions for new problems
Matthew J. Gazzellone, Dijana Oliver, Dianne Groll and Fabiano A. Gomes

J Psychiatry Neurosci May 04, 2022 47 (3) E194-E195; DOI: https://doi.org/10.1503/jpn.220037
Open Access
Prescribing differently for women with first-episode psychosis
Priyadharshini Sabesan, Amuthanila Kasianandan and Lena Palaniyappan

J Psychiatry Neurosci December 21, 2021 46 (6) E711; DOI: https://doi.org/10.1503/jpn.210216
Open Access
Population pharmacokinetics and dosing of long-acting injectable antipsychotics
David D. Kim, Alasdair M. Barr, Reza Rafizadeh and Ric M. Procyshyn

J Psychiatry Neurosci September 01, 2021 46 (5) E516-E517; DOI: https://doi.org/10.1503/jpn.210079
Open Access
Oculogyric crisis: a rare type of dystonia
Sara Boi, Celia Garcia-Malo and Carmen Iglesias Rodríguez

J Psychiatry Neurosci July 01, 2021 46 (4) E429-E430; DOI: https://doi.org/10.1503/jpn.210026
Open Access
Use of MAOIs in severe treatment-resistant depression: back to the old school
Jacob Cookey

J Psychiatry Neurosci July 01, 2021 46 (4) E427-E428; DOI: https://doi.org/10.1503/jpn.200214
Open Access
To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians
Anna Muntingh, Neeltje Batelaan, Willemijn Scholten and Anton J. van Balkom

J Psychiatry Neurosci May 01, 2021 46 (3) E388-E389; DOI: https://doi.org/10.1503/jpn.200099
Open Access
Serotonin syndrome: SSRIs are not the only culprit
Nicolas Garel, Kyle T. Greenway, Karim Tabbane and Ridha Joober

J Psychiatry Neurosci May 01, 2021 46 (3) E369-E370; DOI: https://doi.org/10.1503/jpn.210001
Open Access
Binge eating disorder hidden behind a wall of anxiety disorders
Amy Pipe, Beth Patterson and Michael Van Ameringen

J Psychiatry Neurosci March 01, 2021 46 (2) E208-E209; DOI: https://doi.org/10.1503/jpn200235
Open Access
Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination
Deborah Thompson, Clay M. Delorme, Randall F. White and William G. Honer

J Psychiatry Neurosci March 01, 2021 46 (2) E210-E211; DOI: https://doi.org/10.1503/jpn.210027
Open Access
The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
Nicolas Garel, Kyle T. Greenway and Ridha Joober

J Psychiatry Neurosci January 01, 2021 46 (1) E164-E165; DOI: https://doi.org/10.1503/jpn.200114

Main menu

User menu

Search

More articles from psychopharmacology for the clinician

Pages

Content

Authors & Reviewers

About